Mendelian Randomization Evidence for Cardiovascular Precision Medicine

Christopher J O'Donnell^{1

2

3}

Affiliations

¹ Associate Editor.
² Cardiology Section, Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts.
³ Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Editorial

Christopher J O'Donnell. JAMA Cardiol. 2018.

. 2018 Jul 1;3(7):627-628.

doi: 10.1001/jamacardio.2018.1543.

Christopher J O'Donnell^{1

2

3}

¹ Associate Editor.
² Cardiology Section, Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts.
³ Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Burgess S, Ference BA, Staley JR, Freitag DF, Mason AM, Nielsen SF, Willeit P, Young R, Surendran P, Karthikeyan S, Bolton TR, Peters JE, Kamstrup PR, Tybjærg-Hansen A, Benn M, Langsted A, Schnohr P, Vedel-Krogh S, Kobylecki CJ, Ford I, Packard C, Trompet S, Jukema JW, Sattar N, Di Angelantonio E, Saleheen D, Howson JMM, Nordestgaard BG, Butterworth AS, Danesh J; European Prospective Investigation Into Cancer and Nutrition–Cardiovascular Disease (EPIC-CVD) Consortium. Burgess S, et al. JAMA Cardiol. 2018 Jul 1;3(7):619-627. doi: 10.1001/jamacardio.2018.1470. JAMA Cardiol. 2018. PMID: 29926099 Free PMC article.